The strong institutional accumulation, especially by BlackRock and Geode, combined with a $17.7M insider buy, signals high conviction in ARTV's pipeline or upcoming catalyst. However, the 45-day 13F reporting lag means these positions may already be stale. Monitor for any pipeline updates (clinical trial data, FDA interactions) that could justify this buildup.
ARTV drugs
ARTV drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 17 $11.74entry
- T+1 · 3mo ago −0.51%α +0.16% · $11.68
- T+5 · 3mo ago −1.87%α −0.68% · $11.52
- T+20 · 2mo ago −24.11%α −22.13% · $8.91
- T+60 · 7d ago −65.42%α −62.47% · $4.06
How similar events traded
Executive Summary
A strong institutional cluster formed in ARTV during 2026-Q2, with 6 mega-passive and asset-manager buyers accumulating $9.9M in net new holdings, overwhelmingly dominated by BlackRock ($5.4M added) and Geode ($2.8M added). The sole seller, Morgan Stanley, exited nearly completely. This buying coincides with a single open-market insider purchase of $17.7M, creating a rare confluence of institutional and insider conviction. The cluster is almost entirely passive/index-driven, which slightly tempers the signal, but the sheer scale and unanimity of the accumulation is notable for a small-cap biotech.
Key Financial Metrics
Institutional Positions
Net institutional flow: $9.9M
▲ Buyers (6)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| BlackRock | DOUBLED | +225.6% | $6.7M | $5.4M |
| Geode | DOUBLED | +247.9% | $3.4M | $2.8M |
| State Street | DOUBLED | +362.7% | $1.6M | $1.4M |
| Dimensional Fund Advisors | DOUBLED | +120% | $435.0K | $304.0K |
| Goldman Sachs | ADD | +37.6% | $153.0K | $79.0K |
| JPMorgan | DOUBLED | +1779.4% | $40.0K | $39.0K |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | NEAR_EXIT | -86.5% | $105.0K | -$84.0K |
Key Facts
- 6 institutional buyers vs 1 seller in 2026-Q2
- Net institutional inflow of $9.9M into ARTV
- BlackRock doubled its position to $6.7M (largest buyer)
- Geode doubled to $3.4M; State Street quadrupled to $1.6M
- Morgan Stanley nearly exited (-86.5% of shares)
- Concurrent insider open-market buying of $17.7M (1 buyer)
- Cluster dominated by mega-passive managers (BlackRock, Geode, State Street, JPMorgan, Goldman Sachs)
Financial Impact
6 institutions accumulated $9.9M in net new ARTV holdings during Q2 2026, while 1 seller reduced by $84K. Total institutional holdings in the cluster rose to $12.4M.
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound
- Cluster is dominated by passive/index funds, not active managers with alpha
- Small-cap biotech with limited float, high volatility risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ARTV-2026-Q2 |
Track record
33 reports on ARTV
11 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +66.32% at T+60 after the Jun 8, 2026 report. 17 of 18 went positive at some point.
Filters
- Nov 9, 20267d ago 8-K/A Bearish 7/10 Entry $4.06 settles Dec 9
- Nov 3, 202613d ago Insider Cluster Bearish 6/10 Entry $4.22 settles Dec 3
- Oct 27, 202620d ago 8-K Bearish 6/10 Entry $4.27 settles Nov 24
- Oct 6, 20265w ago 144 Neutral 3/10 Entry $7.00 to $4.21 ▼ −39.93% −38.69% vs SPY
- Sep 11, 20269w ago 8-K Neutral 3/10 Entry $10.14 to $6.77 ▼ −33.23% −35.50% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Bearish 5/10 Entry $10.42 to $6.80 ▲ +34.74% +37.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers